Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitecardiokinetix.com
Twitter@CardioKinetics
CategoryMedical
Phone(650) 364-7016
Emailmargie@cardiokine...
Employees
Founded2003

Offices

Menlo Park, USA
925 Hamilton Avenue,
Menlo Park, CA, 94025
USA

People

CFO
President & CEO & Board Director
VP, Clinical Affairs
VP, Regulatory Affairs & Quality Assurance
VP, Therapy Development
VP, Operations
VP - Europe
Board Director
Show All People

Funding

Tags

CardioKinetix

The Company, based in Menlo Park, has developed a novel transcatheter implant called the PARACHUTETM Ventricular Partitioning Device (PARACHUTETM). The PARACHUTETM intends to treat heart failure resulting from a heart attack or myocardial infarction in millions of patients worldwide by improving overall cardiac function.

Recent Milestones

Videos

Screenshots

Sources

  1. CardioKinetix Raises $44M in Series E Financing (finsmes.com) [edit]
  2. CardioKinetix Adds $4M to $44M Series E for Heart Implant (pevc.dowjones.com) [edit]
  3. CARDIOKINETIX COMPLETES $23M SECOND TRANCHE OF SERIES E FINANCING (finsmes.com) [edit]
Edit This Page
Last Edited 3/21/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy